Literature DB >> 23965644

Differences in the glucuronidation of resveratrol and pterostilbene: altered enzyme specificity and potential gender differences.

Ryan W Dellinger1, Angela M Gomez Garcia, Frank L Meyskens.   

Abstract

Resveratrol, a natural polyphenol found in grapes, berries and other plants, has been proposed as an ideal chemopreventative agent due to its plethora of health promoting activities. However, despite its lofty promise as a cancer prevention agent its success in human clinical trials has been limited due to its poor bioavailability. Thus, interest in other natural polyphenols is intensifying including the naturally occurring dimethylated analog of resveratrol, pterostilbene. The UDP-glucuronosyltransferase (UGT) family of enzymes plays a vital role in the metabolism of both resveratrol and pterostilbene. The current study sought to elucidate the UGT family members responsible for the metabolism of pterostilbene and to examine gender differences in the glucuronidation of resveratrol and pterostilbene. We demonstrate that UGT1A1 and UGT1A3 are mainly responsible for pterostilbene glucuronidation although UGT1A8, UGT1A9 and UGT1A10 also had detectable activity. Intriguingly, UGT1A1 exhibits the highest activity against both resveratrol and pterostilbene despite altered hydroxyl group specificity. Using pooled human liver microsomes, enzyme kinetics were determined for pterostilbene and resveratrol glucuronides. In all cases females were more efficient than males, indicating potential gender differences in stilbene metabolism. Importantly, the glucuronidation of pterostilbene is much less efficient than that of resveratrol, indicating that pterostilbene will have dramatically decreased metabolism in humans.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23965644      PMCID: PMC4487664          DOI: 10.2133/dmpk.dmpk-13-rg-012

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  37 in total

1.  Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway.

Authors:  Yi-Siou Chiou; Mei-Ling Tsai; Kalyanam Nagabhushanam; Yin-Jen Wang; Chih-Hsiung Wu; Chi-Tang Ho; Min-Hsiung Pan
Journal:  J Agric Food Chem       Date:  2011-02-28       Impact factor: 5.279

2.  Species and gender differences affect the metabolism of emodin via glucuronidation.

Authors:  Wei Liu; Lan Tang; Ling Ye; Zheng Cai; Bijun Xia; Jiajie Zhang; Ming Hu; Zhongqiu Liu
Journal:  AAPS J       Date:  2010-05-14       Impact factor: 4.009

3.  Structural identification of mouse urinary metabolites of pterostilbene using liquid chromatography/tandem mass spectrometry.

Authors:  Xi Shao; Xiaoxin Chen; Vladimir Badmaev; Chi-Tang Ho; Shengmin Sang
Journal:  Rapid Commun Mass Spectrom       Date:  2010-06-30       Impact factor: 2.419

Review 4.  Resveratrol bioavailability and toxicity in humans.

Authors:  Charles-Henry Cottart; Valérie Nivet-Antoine; Christelle Laguillier-Morizot; Jean-Louis Beaudeux
Journal:  Mol Nutr Food Res       Date:  2010-01       Impact factor: 5.914

5.  Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells.

Authors:  Min-Hsiung Pan; Yi-Siou Chiou; Wei-Jen Chen; Ju-Ming Wang; Vladimir Badmaev; Chi-Tang Ho
Journal:  Carcinogenesis       Date:  2009-05-15       Impact factor: 4.944

6.  Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction.

Authors:  Shuji Ohno; Shizuo Nakajin
Journal:  Drug Metab Dispos       Date:  2008-10-06       Impact factor: 3.922

7.  Inactivation by UDP-glucuronosyltransferase enzymes: the end of androgen signaling.

Authors:  Sarah Chouinard; Mei-Fei Yueh; Robert H Tukey; Frank Giton; Jean Fiet; Georges Pelletier; Olivier Barbier; Alain Bélanger
Journal:  J Steroid Biochem Mol Biol       Date:  2008-03-13       Impact factor: 4.292

8.  Identification of UDP-glucuronosyltransferase 1A10 in non-malignant and malignant human breast tissues.

Authors:  Athena Starlard-Davenport; Beverly Lyn-Cook; Anna Radominska-Pandya
Journal:  Steroids       Date:  2008-02-03       Impact factor: 2.668

9.  Functional characterization of low-prevalence missense polymorphisms in the UDP-glucuronosyltransferase 1A9 gene.

Authors:  Kristine C Olson; Ryan W Dellinger; Qing Zhong; Dongxiao Sun; Shantu Amin; Thomas E Spratt; Philip Lazarus
Journal:  Drug Metab Dispos       Date:  2009-07-09       Impact factor: 3.922

10.  Up-regulation of UDP-glucuronosyltransferase (UGT) 1A4 by 17beta-estradiol: a potential mechanism of increased lamotrigine elimination in pregnancy.

Authors:  Huiqing Chen; Kyunghee Yang; Suyoung Choi; James H Fischer; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2009-06-22       Impact factor: 3.922

View more
  22 in total

1.  Sex: A change in our guidelines to authors to ensure that this is no longer an ignored experimental variable.

Authors:  James R Docherty; S Clare Stanford; Reynold A Panattieri; Steve P H Alexander; Giuseppe Cirino; Christopher H George; Daniel Hoyer; Angelo A Izzo; Yong Ji; Elliot Lilley; Christopher G Sobey; Phil Stanley; Barbara Stefanska; Gary Stephens; Mauro Teixeira; Amrita Ahluwalia
Journal:  Br J Pharmacol       Date:  2019-08-23       Impact factor: 8.739

2.  Enzymatic analysis of glucuronidation of synthetic cannabinoid 1-naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FDU-PB-22).

Authors:  Sabrina Jones; Azure L Yarbrough; Amal Shoeib; John M Bush; William E Fantegrossi; Paul L Prather; Anna Radominska-Pandya; Ryoichi Fujiwara
Journal:  Xenobiotica       Date:  2019-03-20       Impact factor: 1.908

Review 3.  Pharmacological basis and new insights of resveratrol action in the cardiovascular system.

Authors:  Chak Kwong Cheng; Jiang-Yun Luo; Chi Wai Lau; Zhen-Yu Chen; Xiao Yu Tian; Yu Huang
Journal:  Br J Pharmacol       Date:  2019-12-08       Impact factor: 8.739

4.  Comparative toxicokinetics of Trans-resveratrol and its major metabolites in Harlan Sprague Dawley rats and B6C3F1/N mice following oral and intravenous administration.

Authors:  Esra Mutlu; Seth T Gibbs; Natalie South; Jessica Pierfelice; Brian Burback; Dori Germolec; Suramya Waidyanatha
Journal:  Toxicol Appl Pharmacol       Date:  2020-03-20       Impact factor: 4.219

Review 5.  Dietary Phytoestrogens and Their Metabolites as Epigenetic Modulators with Impact on Human Health.

Authors:  Victor Stefan Ionescu; Alexandra Popa; Andrei Alexandru; Emilia Manole; Mihaela Neagu; Sevinci Pop
Journal:  Antioxidants (Basel)       Date:  2021-11-26

6.  Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer.

Authors:  Swati Dhar; Avinash Kumar; Agnes M Rimando; Xu Zhang; Anait S Levenson
Journal:  Oncotarget       Date:  2015-09-29

7.  Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study.

Authors:  Ryan W Dellinger; Santiago Roel Santos; Mark Morris; Mal Evans; Dan Alminana; Leonard Guarente; Eric Marcotulli
Journal:  NPJ Aging Mech Dis       Date:  2017-11-24

8.  Chemopreventive effects of pterostilbene through p53 and cell cycle in mouse lung of squamous cell carcinoma model.

Authors:  Omchit Surien; Ahmad Rohi Ghazali; Siti Fathiah Masre
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

Review 9.  Role of Natural Stilbenes in the Prevention of Cancer.

Authors:  J Antoni Sirerol; María L Rodríguez; Salvador Mena; Miguel A Asensi; José M Estrela; Angel L Ortega
Journal:  Oxid Med Cell Longev       Date:  2015-12-21       Impact factor: 6.543

10.  Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer.

Authors:  Swati Dhar; Avinash Kumar; Liangfen Zhang; Agnes M Rimando; Janice M Lage; Jack R Lewin; Azeddine Atfi; Xu Zhang; Anait S Levenson
Journal:  Oncotarget       Date:  2016-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.